(NYSE:DVA). The number of moderate SELL recommendations on the stock are 0, while the stock has 3 HOLD recommendations. Earnings, adjusted for non-recurring costs, came to $1.01 per share.
Advertisement
The analysts have 1.75 rating on DaVita healthCare Partners Inc.
Foster Dykema Cabot & Co Inc, which manages about $1.07B and $410.53M US Long portfolio, upped its stake in Merck & Co.
04/21/2014 – DaVita healthCare Partners Inc. was upgraded to “buy” by analysts at Ned Davis Research. Resolute Energy Corporation (NYSE:REN) quarterly performance is 3043.61% while its year to date (YTD) performance is 1963.22%. Stock value has moved between $13.77 – 31.67 in last one year.
DaVita HealthCare Partners Inc. has lost 4.12% in the last five trading days and dropped 16.03% in the last 4 weeks. The ROI is 6.20% and the return on equity for DaVita HealthCare Partners Inc.as stated earlier, is now at 7.50%.The return on assets (ROA) for DaVita HealthCare Partners Inc.is 1.90%. The number of shares now owned by investors are 209.71 mln.
The return on investment (ROI) is the money a company has made or lost on an investment – in simple terms. ROA is calculated by dividing the total annual earnings by the company’s total assets. The stock has earnings growth of 169.40% yoy and showed a high EPS growth of 15.40% over the past five years. (NYSE:DVA) price to sales (P/S) ratio is 0.99.
The price/earnings ratio (P/E) is one of the best known investment valuation indicators. They now have a Dollars 82 price target on the stock. Zacks Investment Research’s price objective would suggest a potential upside of 9.07% from the stock’s previous close. It helps to provide a more holistic picture with the P/E ratio. They now have a Dollars 92 price target on the stock. News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for DaVita healthCare Partners Inc. with MarketBeat.com’s FREE daily email newsletter.
DaVita HealthCare Partners Inc. has a 52-week low of 6.32% and 52-week high of -18.14%. It experienced higher than average volume on day. MA here stands for moving average. The stock had a trading volume of 6.4 M shares.
The technical stats for DaVita HealthCare Partners Inc. are as follows.
Advertisement
DaVita healthCare Partners Inc. had its “neutral” rating reiterated by analysts at Susquehanna. The firm has a SMA 50 (Simple Moving Average) of $10.92 and a SMA 200-(Simple Moving Average) of $10.55. The Irving Texas 75039 based company has been outperforming the independent oil & gas group over the past 52 weeks, with the stock gaining 64.1%, compared to the industry which has advanced 19.69% over the same period. 8 Analysts reported that the Price Target for DaVita healthCare Partners Inc. might touch $113 high while the Average Price Target and Low price Target is $81.63 and $68 respectively.
